Gastroenterology
Volume 130, Issue 6 , Pages 1588-1594 , May 2006

Acute Gastroenteritis Is Followed by an Increased Risk of Inflammatory Bowel Disease

  • Luis Alberto García Rodríguez

      Affiliations

    • Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain
    • Corresponding Author InformationAddress requests for reprints to: Luis Alberto García Rodríguez, MD, Centro Español de Investigación Farmacoepidemiológica, Almirante 28, 2° 28004 Madrid, Spain
    • ,
  • Ana Ruigómez

      Affiliations

    • Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain
    • ,
  • Julián Panés

      Affiliations

    • Servei de Gastroenterologia, Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain

Received 2 October 2005 ,Accepted 18 January 2006.

References 

  1. Loftus EV . Clinical epidemiology of inflammatory bowel disease (incidence, prevalence, and environmental influences) . Gastroenterology . 2004;126:1504–1517
  2. Treacher DF , Jewell DP . Yersinia colitis associated with Crohn’s disease . Postgrad Med J . 1985;61:173–174
  3. Powell SJ , Wilmot AJ . Ulcerative post-dysenteric colitis . Gut . 1966;7:438–443
  4. Schumacher G, Kollberg B, Sandstedt B, Jorup C, Grillner L, Ljungh A, et al. A prospective study of first attacks of inflammatory bowel disease and non-relapsing colitis. Microbiologic findings . Scand J Gastroenterol . 1993;28:1077–1085
  5. Kallinowski F, Wassmer A, Hofmann MA, Harmsen D, Heesemann J, Karch H, et al. Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease . Hepatogastroenterology . 1998;45:1552–1558
  6. Weber P , Koch M , Heizmann WR , Scheurlen M , Jenss H , Hartmann F . Microbic superinfection in relapse of inflammatory bowel disease . J Clin Gastroenterol . 1992;14:302–308
  7. Rodriguez LA , Ruigomez A . Increased risk of irritable bowel syndrome after bacterial gastroenteritis (cohort study) . BMJ . 1999;318:565–566
  8. Lis Y , Mann RD . The VAMP Research multi-purpose database in the U.K . J Clin Epidemiol . 1995;48:431–443
  9. The General Practice Research Database . Information for Researchers . London, UK: Office for National Statistics; 1994;
  10. Garcia Rodriguez LA , Perez GS . Use of the UK General Practice Research Database for pharmacoepidemiology . Br J Clin Pharmacol . 1998;45:419–425
  11. Lewis JD , Brensinger C , Bilker WB , Strom BL . Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease . Pharmacoepidemiol Drug Saf . 2002;11:211–218
  12. Gupta G , Gelfand JM , Lewis JD . Increased risk for demyelinating diseases in patients with inflammatory bowel disease . Gastroenterology . 2005;129:819–826
  13. Lewis JD , Aberra FN , Lichtenstein GR , Bilker WB , Brensinger C , Strom BL . Seasonal variation in flares of inflammatory bowel disease . Gastroenterology . 2004;126:665–673
  14. Jick H , Jick SS , Derby LE . Validation of information recorded on general practitioner based computerised data resource in the United Kingdom . BMJ . 1991;302:766–768
  15. Bjornsson S , Johannsson JH . Inflammatory bowel disease in Iceland, 1990–1994 (a prospective, nationwide, epidemiological study) . Eur J Gastroenterol Hepatol . 2000;12:31–38
  16. Ekbom A , Helmick C , Zack M , Adami HO . The epidemiology of inflammatory bowel disease (a large, population-based study in Sweden) . Gastroenterology . 1991;100:350–358
  17. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe (is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)) . Gut . 1996;39:690–697
  18. Lanfranchi GA , Michelini M , Brignola C , Campieri M , Cortini C , Marzio L . Epidemiological study on intestinal inflammatory diseases in the Province of Bologna . in Italian G Clin Med . 1976;57:235–245
  19. Calkins BM . A meta-analysis of the role of smoking in inflammatory bowel disease . Dig Dis Sci . 1989;34:1841–1854
  20. Birrenbach T , Bocker U . Inflammatory bowel disease and smoking (a review of epidemiology, pathophysiology, and therapeutic implications) . Inflamm Bowel Dis . 2004;10:848–859
  21. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis . Gut . 2004;53:987–992
  22. Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, et al. Association between Toll-like receptor 4 and inflammatory bowel disease . Inflamm Bowel Dis . 2005;11:567–575
  23. Eckmann L , Karin M . NOD2 and Crohn’s disease (loss or gain of function?) . Immunity . 2005;22:661–667

 Supported in part by a research grant from AstraZeneca R&D, Sweden, and grant C03/02 from Instituto de Salud Carlos III (to J.P.).

PII: S0016-5085(06)00262-9

doi: 10.1053/j.gastro.2006.02.004

Gastroenterology
Volume 130, Issue 6 , Pages 1588-1594 , May 2006

Article Tools

* Image Usage & Resolution